SLN.L - Silence Therapeutics plc

LSE - LSE Delayed price. Currency in GBp
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2018
31/12/2017
31/12/2016
Total revenue
0
0
16
770
Cost of revenue
-
-
-
-
Gross profit
-
-
-
-
Operating expenses
Research development
9,585
9,743
7,943
8,711
Selling general and administrative
10,801
10,828
6,464
3,965
Total operating expenses
20,386
20,571
14,407
12,676
Operating income or loss
-20,386
-20,571
-14,391
-11,906
Interest expense
-
-
15
-
Total other income/expenses net
-
-
-
-
Income before tax
-20,337
-20,526
-3,775
-10,362
Income tax expense
-2,403
-2,115
-2,157
-1,922
Income from continuing operations
-17,934
-18,411
-1,618
-8,440
Net income
-17,934
-18,411
-1,618
-8,440
Net income available to common shareholders
-17,934
-18,411
-1,618
-8,440
Reported EPS
Basic
-
-0.26
-0.02
-0.12
Diluted
-
-0.26
-0.02
-0.12
Weighted average shares outstanding
Basic
-
70,313
69,943
69,802
Diluted
-
70,313
69,943
69,802
EBITDA
-
-20,172
-3,327
-11,596
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more